Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$411 Mln
P/E Ratio
--
P/B Ratio
16.2
Industry P/E
--
Debt to Equity
0.14
ROE
-0.81 %
ROCE
-59.04 %
Div. Yield
0 %
Book Value
0.94
EPS
-0.7
CFO
$-85.57 Mln
EBITDA
$-92.00 Mln
Net Profit
$-103.93 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Clearpoint Neuro Inc (CLPT)
| -4.36 | 18.44 | -13.47 | 179.66 | 20.06 | 31.65 | -11.12 |
|
BSE Sensex*
| 2.54 | 3.65 | 5.71 | 8.83 | 11.73 | 20.10 | 11.34 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Clearpoint Neuro Inc (CLPT)
| 125.00 | -19.83 | -24.51 | -29.39 | 231.04 | 205.73 | -42.73 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.49 | 10,562.04 | 12.43 | 12.69 | |
| 72.62 | 10,050.19 | 97.07 | 2.52 | |
| 164.04 | 8,847.72 | -- | -25.23 | |
| 297.32 | 11,609.25 | 277.57 | 3.65 |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided... interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California. Address: 120 S. Sierra Avenue, Solana Beach, CA, United States, 92075 Read more
President, CEO & Director
Mr. Joseph Michael Burnett
President, CEO & Director
Mr. Joseph Michael Burnett
Headquarters
Solana Beach, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Clearpoint Neuro Inc (CLPT) stood at $ 39 Mln as on 31-Dec-24
The share price of Clearpoint Neuro Inc (CLPT) is $14.71 (NASDAQ) as of 28-Apr-2025 16:00 EDT. Clearpoint Neuro Inc (CLPT) has given a return of 20.06% in the last 3 years.
Clearpoint Neuro Inc (CLPT) has a market capitalisation of $ 411 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Clearpoint Neuro Inc (CLPT) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Clearpoint Neuro Inc (CLPT) and enter the required number of quantities and click on buy to purchase the shares of Clearpoint Neuro Inc (CLPT).
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California. Address: 120 S. Sierra Avenue, Solana Beach, CA, United States, 92075
The CEO & director of Mr. Joseph Michael Burnett. is Clearpoint Neuro Inc (CLPT), and CFO & Sr. VP is Mr. Joseph Michael Burnett.
There is no promoter pledging in Clearpoint Neuro Inc (CLPT).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| Clearpoint Neuro Inc (CLPT) | Ratios |
|---|---|
|
Return on equity(%)
|
-81.24
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
-60.25
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Clearpoint Neuro Inc (CLPT) was $0 Mln.
$0.01
(
